Organised by the FIP Community Pharmacy Section in collaboration with the FIP Social and Administrative Pharmacy Section
Chronic diseases constitute the largest burden of disease in our health systems. This implicates the need to look at measures to improve prevention and management of chronic disease in primary care. However, to meet the chronic disease challenge successfully, pharmacy can effectively contribute to tackle one of its largest — and most costly — components: cardiovascular disease (CVD) and diabetes.
CVD is the number one cause of mortality in most OECD countries and accounts for around a third of all deaths. Many more patients suffer considerable loss in their quality of life due to CVD, particularly through stroke and congestive heart failure. Rising levels of obesity, high cholesterol and blood pressure have led to more people being diagnosed with metabolic syndrome, which in turn is a key risk factor for CVD and diabetes.
By using pharmacy for improved outcomes, our nations can better meet the challenges of chronic diseases, leading to:
09:00 – 09:10 Introduction by the chairs
10:20 – 10:40 Coffee/tea break
11:50 – 12:00 Conclusion by the chairs
At the end of this session, participants will be able to:
Type of session: Knowledge-based